Navigation Links
Pharsight to Present on IVIVC at Bioequivalence & Bioavailability Strategies Conference
Date:6/23/2008

Talk Will Cover the Use of Pharsight Software for In-Vitro / In-Vivo

Correlation Modeling in Drug Development

MOUNTAIN VIEW, Calif., June 23 /PRNewswire-FirstCall/ -- Pharsight(R) Corporation (Nasdaq: PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical drug development, today announced that Jason Chittenden, MS, Director of Training and Pre-Sales, will speak to members of the pharmaceutical and biotechnology industries attending the Dissolution Testing, Bioequivalence & Bioavailability Strategies Conference, to be held in London, United Kingdom, by Visiongain, at The Grosvenor -- Victoria Hotel, June 26th and 27th, 2008.

Mr. Chittenden will give a lecture on the use of Pharsight's software for in-vitro/in-vivo correlation (IVIVC) and its benefits in formulation design, bioequivalence, and development of dissolution specifications. Understanding and controlling the relationship between in-vitro release and in-vivo response in a compound plays a critical role in the development of modified-release formulations, generics, fixed-dose combination products, and drug delivery systems. The earlier in the drug development process IVIVC is implemented, the easier and more cost effective it is to implement all future changes in formulations.

"Doing dissolution analyses with IVIVC is a fast and inexpensive method for obtaining optimal formulations as opposed to slow, expensive bioavailability or bioequivalence (BA/BE) studies that provide hit or miss results," said Shawn O'Connor, president, CEO, and chairman of Pharsight. "Pharsight's IVIVC Toolkit(TM) for WinNonlin(R) guides researchers to perform the right BA/BE studies and eliminate many that are unn
'/>"/>

SOURCE Pharsight Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Pharsight Achieves First License Sale for Public-Source Database
2. Pharsight to Present at ROeS Seminar in Bern, Switzerland on September 10 & 11, 2007
3. Pharsight Expands Strategic Consulting Services Team
4. Pharsight Hosts Fourth Annual PKS User Group Meeting
5. Pharsight Invited to Present on Winning Strategies for R&D Productivity at New York Pharma Forum on October 15, 2007
6. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
7. Pharsight Announces 1-For-3 Reverse Stock Split
8. Pharsight Signs Third WinNonlin(R) AutoPilot(TM) Customer
9. Pharsights Reporting and Analysis Services Business Reaches Quality Assurance Milestone
10. Pharsight Announces Fiscal Third Quarter 2008 Earnings Release Date and Conference Call
11. Pharsight Achieves $7.4 Million in Quarterly Revenue
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014 ... of the biomaterial family and are increasingly becoming ... body fluids and tissues without having a negative ... used as tissue replacement and tissue repair materials ... materials such as ceramics, glass, glass-ceramics, and composites. ...
(Date:9/23/2014)... Kamal Rashid , PhD, director of ... Center (BETC) and research professor of biology and biotechnology ... an international two-day event focused on biomanufacturing set for ... the event will bring together leaders of companies from ... and produce human therapeutics. “The growth curve for biomanufacturing ...
(Date:9/23/2014)... 2014 This is a professional ... the Phenolic Resin industry in Global and China.The ... including definitions, applications and industry chain structure. Global ... provided with a focus on history, developments, trends ... between the international and Chinese situation is also ...
(Date:9/23/2014)... de Reuil, France (PRWEB) September 23, 2014 ... to protection of laboratory personnel since 1968 and Burdinola, ... the development of a new filtered fume hood. ... above their laboratory fume hood, Burdinola will now offer ... for filtering a wide range of chemicals, best-in-class detection ...
Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 3Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2
... , RESTON, Va., July 9 Mirixa Corporation, the ... the hiring of three new members to its growing ... FASCP, Kim Swiger, RPh, and Paul Miller, MS, RPh. ... closely with Mirixa,s pharmacy partners, state and national pharmacy ...
... FRANCISCO, Calif., July 9 Poniard Pharmaceuticals, Inc. (Nasdaq: ... therapies, today announced the appointment of Gary A. Lyons, to ... number of directors on the Poniard board to ten. , ... to help guide us as we move toward our goal ...
... , SUNNYVALE, Calif., July 9 Cepheid (Nasdaq: CPHD ... second quarter ended June 30, 2009, on Thursday, July 30, 2009, ... will host a management presentation at 2 p.m. Pacific Time on ... the live webcast, please visit Cepheid,s website at www.cepheid.com/investors ...
Cached Biology Technology:Mirixa Corporation Announces Key New Hires 2Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 2Poniard Pharmaceuticals Appoints Gary A. Lyons to Board of Directors 3Cepheid Schedules 2009 Second Quarter Financial Results Announcement and Webcast 2
(Date:9/23/2014)... Scientists have scoured cow rumens and termite guts for ... for the production of next-generation biofuels, but some of ... human lower intestine, researchers report. , Their study ... Academy of Sciences , is the first to use ... the human gut can digest fiber, breaking it down ...
(Date:9/23/2014)... could be as good for your mental as your ... by the University of Warwick,s Medical School using data ... BMJ Open focused on mental wellbeing and ... associated with an individual,s fruit and vegetable consumption. , ... or more portions of fruit and vegetables a day, ...
(Date:9/23/2014)... organisms, including humans, have parasitic DNA fragments called "jumping ... instructions in the process. And that phenomenon can result ... the University of Rochester now report that the "jumping ... when a multi-function protein stops keeping them in check ... In a study published today in Nature Communications ...
Breaking Biology News(10 mins):Search for better biofuels microbes leads to the human gut 2Search for better biofuels microbes leads to the human gut 3Eating five a day may keep the blues away 2A multi-function protein is key to stopping genomic parasites from 'jumping' 2
... replacement surgeries can help relieve joint pain common ... the debris from prosthetic joints leads to aseptic ... a Wayne State University researcher determined that the ... disintegration. There was one caveat, however: there are ...
... female mosquito cannot tell if the male that she has ... her eggs, according to a new study from scientists at ... journal Proceedings of the National Academy of Sciences , ... of malaria by interfering with the mosquitoes, ability to reproduce. ...
... ALAMOS, New Mexico, August 8, 2011A Los Alamos National ... the first time the critical role that an elusive ... aid in treatment of peptic ulcers or acid reflux ... waste into transportation fuels. In a paper appearing ...
Cached Biology News:Wayne State researcher discovers antibiotic useful for localized treatment of bone wear 2Mosquitoes can't spot a spermless mate 2Mosquitoes can't spot a spermless mate 3Researchers use neutrons to spy on the elusive hydronium ion 2
HAMP Immunogen: HAMP (AAH20612, 25 a.a. ~ 85 a.a) full length recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
... peptide transporter 2 (APT2) ... transporter PSF2) (Peptide supply ... transporter involved in antigen ... Antigen: ...
Raised to arginine vasopressin coupled to bovine thyroglobulin with carbodiimide ....
Chicken polyclonal to HAGH ( Abpromise for all tested applications). Antigen: Synthetic peptide, corresponding to N terminal amino acids 110-260 of Human HAGH. Entrez GeneID: 3029 Swiss ...
Biology Products: